Medicine for treating atrophic gastritis

A technology for atrophic gastritis and medicine, which is applied in the field of medicine for the treatment of atrophic gastritis, can solve the problems of many side effects and easy recurrence, and achieve the effect of quick effect, small dosage and convenient administration

Inactive Publication Date: 2017-03-22
HENAN BALING ELECTRONICS TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine has quick onset and high clinical remission rate, but it is easy to

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] A medicine for treating atrophic gastritis, the main raw materials in parts by weight are: 8 parts of lamivudine, 5 parts of artemisinin, 5 parts of triazolam, 6 parts of polyvinylpyrrolidone, 0.04 parts of scopoletin, 2 parts of sentan, 4 parts of metronidazole, 1 part of biotin, 4 parts of bismuth subnitrate, 10 parts of sodium bicarbonate.

[0016] A preparation method of a medicine for treating atrophic gastritis, the specific steps are:

[0017] First, in a pharmaceutical-grade clean area, weigh lamivudine, artemisinin, triazolam, polyvinylpyrrolidone, scopoletin, bosentan, metronidazole, biotin, hyponitrate Bismuth and sodium bicarbonate, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 4 minutes, controlled RSD ≤ 5%, after mixing, pressed into tablets and dried at low temperature, the temperature was controlled at 4°C, and packaged. Drugs for the treatment of atrophic gastritis.

Embodiment 2

[0019] A medicine for treating atrophic gastritis, the main raw materials in parts by weight are: 10 parts of lamivudine, 6 parts of artemisinin, 5 parts of triazolam, 8 parts of polyvinylpyrrolidone, 0.07 parts of scopoletin, 2 parts of sentan, 5 parts of metronidazole, 1 part of biotin, 4 parts of bismuth subnitrate, 12 parts of sodium bicarbonate.

[0020] A preparation method of a medicine for treating atrophic gastritis, the specific steps are:

[0021] First, in a pharmaceutical-grade clean area, weigh lamivudine, artemisinin, triazolam, polyvinylpyrrolidone, scopoletin, bosentan, metronidazole, biotin, hyponitrate Bismuth and sodium bicarbonate, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 4 minutes, controlled RSD ≤ 5%, after mixing, pressed into tablets and dried at low temperature, the temperature was controlled at 4°C, and packaged. Drugs for the treatment of atrophic gastritis.

Embodiment 3

[0023] A medicine for treating atrophic gastritis, the main raw materials in parts by weight are: 11 parts of lamivudine, 7 parts of artemisinin, 6 parts of triazolam, 9 parts of polyvinylpyrrolidone, 0.09 parts of scopoletin, 5 parts of sentan, 6 parts of metronidazole, 2 parts of biotin, 5 parts of bismuth subnitrate, 16 parts of sodium bicarbonate.

[0024] A preparation method of a medicine for treating atrophic gastritis, the specific steps are:

[0025] First, in a pharmaceutical-grade clean area, weigh lamivudine, artemisinin, triazolam, polyvinylpyrrolidone, scopoletin, bosentan, metronidazole, biotin, hyponitrate Bismuth and sodium bicarbonate, sieved, mechanically mixed, added ultra-pure water, placed in a pharmaceutical mixer, mixed for 6 minutes, controlled RSD ≤ 5%, after mixing, pressed into tablets and dried at low temperature, the temperature was controlled at 6°C, and packaged. Drugs for the treatment of atrophic gastritis.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine for treating atrophic gastritis. The medicine for treating atrophic gastritis mainly comprises, by weight, 8-14 parts of lamivudine, 5-10 parts of artemisinin, 5-7 parts of triazolam, 6-10 parts of polyvinylpyrrolidone, 0.04-0.15 part of scopoletin , 2-7 parts of bosentan, 4-8 parts of metronidazole, 1-3 parts of biotin, 4-6 parts of bismuth subnitrate and 10-20 parts of sodium bicarbonate. The medicine for treating atrophic gastritis has the advantages that the medicine, which is a western medicine compound preparation, is reasonable in formula, remarkably effective through clinical experiment results and capable of treating symptoms of the atrophic gastritis effectively; the medicine is small in dose, convenient to take, quick in action, exact in curative effect, safe, reliable, free of side effect and low in cost.

Description

technical field [0001] The invention relates to the field of medicine preparation, in particular to a medicine for treating atrophic gastritis. Background technique [0002] Atrophic gastritis is a chronic inflammation or atrophic lesion of the gastric mucosa caused by different etiologies. Clinically, it is mainly divided into three categories: non-atrophic gastritis (superficial gastritis), chronic atrophic gastritis and special type of gastritis. It is a common clinical disease. , frequently-occurring disease, its incidence rate ranks first among all stomach diseases, accounting for more than 80% to 90% of patients receiving gastroscopy, and its incidence rate increases with age. Chronic non-atrophic gastritis can develop into chronic atrophic gastritis, to gastric cancer, which seriously threatens the life of the patient. Western medicine generally believes that the cause of atrophic gastritis is that physical, chemical and biological harmful factors continue to repeate...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K33/24A61K9/20A61P1/04A61K31/352A61K31/366A61K31/4164A61K31/4188A61K31/506A61K31/513A61K31/5517A61K33/00
CPCA61K31/513A61K9/2004A61K31/352A61K31/366A61K31/4164A61K31/4188A61K31/506A61K31/5517A61K33/00A61K33/245
Inventor 不公告发明人
Owner HENAN BALING ELECTRONICS TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap